- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GE's Lombardo lands at ALI as company forms U.S. unit
GE's Lombardo lands at ALI as company forms U.S. unitPACS veteran Tony Lombardo didn't take long to find a new job. Ultrasound miniPACS developer ALI Technologies has tapped Lombardo to head up ALI Imaging Systems, a wholly owned subsidiary that
GE's Lombardo lands at ALI as company forms U.S. unit
PACS veteran Tony Lombardo didn't take long to find a new job. Ultrasound miniPACS developer ALI Technologies has tapped Lombardo to head up ALI Imaging Systems, a wholly owned subsidiary that will serve as the Richmond, British Columbia-based firm's U.S. field sales organization. ALI Imaging Systems will be based near Milwaukee, WI.
Lombardo, who left his post as general manager of sales for the Integrated Imaging Solutions division of GE Medical Systems in June (PNN 7/98), will assume the title of president of ALI Imaging Systems and vice president of ALI Technologies. He will also be joined by another former GE employee in ALI's executive ranks.
John LaLonde, who recently served as global engineering manager in the IIS division, has been named vice president of technology. LaLonde left GE in early 1998 and then served as vice president of Aksys, a developer of home hemodialysis products.
In other personnel moves, president Chris Hanna has left the company to join the Mayo Clinic as an expert in radiology informatics. Upon Hanna's departure on August 31, CEO Greg Peet will add the duties and title of president to his responsibilities. Hanna, who cofounded ALI, will continue to serve on the company's board of directors.
- Search again
- Homepage
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
